Tus-Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 3/6
Tus-Pharmaceutical Group has a total shareholder equity of CN¥720.3M and total debt of CN¥117.4M, which brings its debt-to-equity ratio to 16.3%. Its total assets and total liabilities are CN¥1.2B and CN¥443.2M respectively.
Key information
16.3%
Debt to equity ratio
CN¥117.42m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥166.60m |
| Equity | CN¥720.29m |
| Total liabilities | CN¥443.19m |
| Total assets | CN¥1.16b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 000590's short term assets (CN¥554.4M) exceed its short term liabilities (CN¥266.5M).
Long Term Liabilities: 000590's short term assets (CN¥554.4M) exceed its long term liabilities (CN¥176.7M).
Debt to Equity History and Analysis
Debt Level: 000590 has more cash than its total debt.
Reducing Debt: 000590's debt to equity ratio has increased from 5.1% to 16.3% over the past 5 years.
Debt Coverage: 000590's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 000590's interest payments on its debt are well covered by EBIT.